BNP PARIBAS FINANCIAL MARKETS - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 163 filers reported holding ALLOGENE THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.5%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,806,757
+53.2%
569,955
+140.2%
0.00%
+100.0%
Q2 2023$1,179,356
-9.8%
237,295
-10.3%
0.00%
-50.0%
Q1 2023$1,307,297
-15.8%
264,635
+7.2%
0.00%0.0%
Q4 2022$1,552,297
-100.0%
246,788
-14.4%
0.00%
-60.0%
Q3 2022$3,114,612,000
+768.6%
288,390
+816.8%
0.01%
+400.0%
Q2 2022$358,598,000
+330.6%
31,456
+244.1%
0.00%
Q1 2022$83,275,000
-72.6%
9,141
-55.2%
0.00%
Q4 2021$304,353,000
-23.3%
20,399
+32.1%
0.00%
-100.0%
Q3 2021$396,834,000
+477.2%
15,441
+485.8%
0.00%
Q2 2021$68,747,000
-72.0%
2,636
-62.1%
0.00%
Q1 2021$245,300,000
+69.8%
6,949
+21.4%
0.00%
Q4 2020$144,449,000
-69.8%
5,723
-54.8%
0.00%
-100.0%
Q3 2020$477,861,000
-46.3%
12,672
-39.0%
0.00%
-50.0%
Q2 2020$889,414,000
+111.0%
20,771
-4.2%
0.00%
+100.0%
Q1 2020$421,576,000
+191.1%
21,686
+289.1%
0.00%
Q4 2019$144,813,000
-20.5%
5,574
-16.6%
0.00%
Q3 2019$182,200,000
+97.2%
6,685
+94.3%
0.00%
Q2 2019$92,391,0003,4410.00%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 1,798,163$16,381,0009.53%
Wildcat Capital Management, LLC 2,128,370$19,389,0004.96%
TPG GP A, LLC 18,716,306$170,506,0002.11%
Pier Capital, LLC 746,669$6,802,0000.87%
Coastal Bridge Advisors, LLC 401,929$3,662,0000.84%
HARBOR CAPITAL ADVISORS, INC. 92,755$845,0000.40%
Lombard Odier Asset Management (Switzerland) SA 501,219$4,566,0000.36%
Navalign, LLC 74,271$623,0000.26%
PDT Partners, LLC 241,592$2,201,0000.19%
GSA CAPITAL PARTNERS LLP 148,804$1,356,0000.18%
View complete list of ALLOGENE THERAPEUTICS INC shareholders